1. Microbiology

Category Archives: Microbiology

53rd ICAAC: Media registration now open

Posted on by

Public release date: 10-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

News media registration for the annual infectious diseases meeting of the American Society for Microbiology (ASM) is now open. The 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be held September 10-13, 2013 at the Colorado Convention Center in Denver, Colorado.

Known as the preeminent world meeting for presenting new information on clinical and basic research in infectious diseases and anti-infective therapy, ICAAC has also traditionally served as a forum for the introduction of new antimicrobial agents. It is the largest infectious disease meeting held in the United States.

The opening keynote session will focus on the future of antibiotic therapy, urging infectious disease professionals to rethink the "one diseaseone pathogenone drug," paradigm currently used to treat disease in favor of more multifaceted and integrated therapeutic interventions aimed at restoring the health of all sick compartments involved in infection.

This year's meeting will also feature a special address by Trevor Mundel of the Bill and Melinda Gates Foundation who will speak on the importance of innovation to address infectious diseases in the developing world. Dr. Mundel will address current vaccine discovery programs, strategies for the future, neglected diseases and plans for accelerating research and development efforts for low resource settings through new partnerships and programs.

The ASM Office of Communications will host a full-service press room with Internet access, telephones, computers, photocopy and fax machines, and refreshments. Streaming audio and video of daily press conferences will be available over the Internet for reporters covering from a distance. Programs and abstracts, as well as an embargoed online press kit featuring tipsheets, lay-summaries of selected presentations and the press conference schedule will be available in advance of the meeting. For media registration and housing please go to http://bit.ly/53icaacpr.

###

The American Society for Microbiology, headquartered in Washington, D.C., is the largest single life science association, with over 39,000 members worldwide. Its members work in educational, research, industrial, and government settings on issues such as the environment, the prevention and treatment of infectious diseases, laboratory and diagnostic medicine, and food and water safety. The ASM's mission is to gain a better understanding of basic life processes and to promote the application of this knowledge for improved health and economic and environmental well-being.

Read more here:
53rd ICAAC: Media registration now open

H7N9 influenza: History of similar viruses gives cause for concern

Posted on by

Public release date: 9-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases. David Morens, Jeffery Taubenberger, and Anthony Fauci, in a paper published in mBio, the online open-access journal of the American Society for Microbiology, describe the history of H7 viruses in animal and human disease and point out that H7 influenza has a tendency to become established in bird, horse, and swine populations and may spillover repeatedly into humans.

"The evidence as a whole is complex and the implications of past outbreaks for predicting the future course of the current H7N9 epizootic [an epidemic among animals] are uncertain," write the authors.

The outbreak of H7N9 earlier this year led China to temporarily close scores of live poultry markets in an effort to limit the spread of the virus. Although this previously unrecognized strain of avian influenza A has now been associated with 132 confirmed human infections and 39 related deaths (as of June 14), the rate at which new cases are recognized has dwindled in recent weeks.

In their minireview, Morens, Taubenberger and Fauci point out that despite this apparent hiatus, viruses like H7N9, which have subtype 7 hemagglutinin, are a cause for heightened concern because of several highly unusual characteristics. First, H7 viruses have repeatedly been involved in numerous explosive poultry outbreaks including incidents in New York, Canada, Mexico, the Netherlands, and Italy, and in almost all of these cases the virus eventually spilled over into humans. Also, H7 viruses have the ability to mutate from a low pathogenicity form to a high pathogenicity form in birds, a scenario that can lead to large-scale culling and ultimately to human exposure to the virus among poultry workers.

H7N9 also shares many characteristics with another influenza strain that continues to spillover into humans: highly pathogenic avian influenza H5N1. Among other commonalities, both viruses have a clinical picture that includes bilateral pneumonia, acute respiratory distress syndrome, and multi-organ failure, and it appears they are both currently unable to easily infect most humans but cause severe disease in individuals with uncharacterized genetic susceptibilities.

The fact that many H7 viruses tend to infect conjunctival cells is also cause for concern. Some, but not all, cases of human H7 infection feature prominent signs and symptoms in the eyes, including itching, swelling, and tearing, that could enhance person-to-person spread in an H7N9 outbreak.

The authors point out that many H7 viruses have adapted to infect mammals, including horses and pigs, which raises the possibility that H7N9 could adapt in a similar fashion. The possibility that H7N9 might infect pigs is particularly troubling, as swine are considered a "mixing vessel" for viruses - a breeding ground for novel viral reassortants like the 2009 H1N1 pandemic influenza strain commonly known as "swine flu".

The sum of these observations is this: we do not know what H7N9 will do next. Although avian influenza viruses have not caused widespread human transmission in 94 years of surveillance, there have been numerous instances of avian influenza spillover and H7N9 "might arguably be more likely than other avian viruses to become human-adapted," write the authors.

Excerpt from:
H7N9 influenza: History of similar viruses gives cause for concern

Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by …

Posted on by

NEW YORK, July 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by Country : France, Germany, Italy, Japan, Spain, UK, US http://www.reportlinker.com/p01517631/Microbiology-Testing-Granular-Analysis-of-the-Global-Market--Supplier-Shares-and-Forecasts-for-over-100-Diseases-by-Country--France-Germany-Italy-Japan-Spain-UK-US.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This DataPack contains 800 tables from Venture Planning Group's new 7-country study, 'Global Microbiology Testing Market: US, Europe, Japan'including supplier shares, and forecasts for over 100 tests. This DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global microbiology testing market during the nextfive years, and assist industry executives in developing effective business, new product development and marketing strategies. Geographic Coverage- France - Germany - Italy - Japan - Spain - UK - USAMarket Segmentation Analysis- Sales and market shares of major suppliers of microbiology products, by country and individual assay.- Volume and sales forecasts for over 100 microbiology procedures, by country, individual test and market segment: - Hospitals - Blood Banks - Commercial/Private Laboratories - Physician Offices/Group Practices - Public Health LaboratoriesWorldwide Market Overview- Estimated universe of laboratories performing microbiology tests by country.- Test volume and sales projections by country.Contains 800 tables

List of Tables

Major Companies Developing or Marketing AIDS Tests Major Companies Developing or Marketing Adenovirus Tests Major Companies Developing or Marketing Bartonella Tests Major Companies Developing or Marketing Campylobacter Tests Major Companies Developing or Marketing Candida Tests Major Companies Developing or Marketing Chlamydia Tests Major Companies Developing or Marketing Clostridium Tests Major Companies Developing or Marketing Coronavirus Tests Major Companies Developing or Marketing Cryptosporidium Tests Major Companies Developing or Marketing CMV Tests Major Companies Developing or Marketing Echovirus Tests Major Companies Developing or Marketing Enterovirus Tests Major Companies Developing or Marketing EBV Tests Major Companies Developing or Marketing Giardia Tests Major Companies Developing or Marketing Gonorrhea Tests Major Companies Developing or Marketing Hantavirus Tests Major Companies Developing or Marketing Helicobacter Pylori Tests Major Companies Developing or Marketing Hepatitis Tests Major Companies Developing or Marketing Herpes Tests Major Companies Developing or Marketing Influenza Tests Major Companies Developing or Marketing Legionella Tests Major Companies Developing or Marketing Lyme Disease Tests Major Companies Developing or Marketing Lymphogranuloma Tests Major Companies Developing or Marketing Malaria Tests Major Companies Developing or Marketing Measles Tests Major Companies Developing or Marketing Meningitis Tests Major Companies Developing or Marketing Microsporidium Tests Major Companies Developing or Marketing Mononucleosis Tests Major Companies Developing or Marketing Mumps Tests Major Companies Developing or Marketing Mycoplasma Tests Major Companies Developing or Marketing Papilloma Virus Tests Major Companies Developing or Marketing Parvovirus Tests Major Companies Developing or Marketing Pneumonia Tests Major Companies Developing or Marketing RSV Tests Major Companies Developing or Marketing Rotavirus Tests Major Companies Developing or Marketing Rubella Tests Major Companies Developing or Marketing Salmonella Tests Major Companies Developing or Marketing Septicemia Tests Major Companies Developing or Marketing Shigella Tests Major Companies Developing or Marketing Staphylococci Tests Major Companies Developing or Marketing Streptococci Tests Major Companies Developing or Marketing Syphilis Tests Major Companies Developing or Marketing Toxoplasmosis Tests Major Companies Developing or Marketing Trichomonas Tests Major Companies Developing or Marketing Tuberculosis Tests Major Companies Developing or Marketing West Nile Tests Major Companies Developing or Marketing Yersinia Tests Worldwide All Market Segments Laboratories Performing Infectious Disease Tests by Country Worldwide All Market Segments Total Infectious Disease Test Volume Forecast by Country Worldwide All Market Segments Total Infectious Disease Diagnostics Market Forecast by Country Infectious Disease Tests Major Issues and Market Potential For Personal Testing France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment France Laboratories Performing Infectious Disease Tests by Market Segment France Hospital Laboratories Performing Infectious Disease Tests by Bed Size France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume France All Market Segments Infectious Disease Test Volume Forecast France Hospital Laboratories Infectious Disease Test Volume Forecast France Blood Banks Infectious Disease Test Volume Forecast France Commercial/Private Laboratories Infectious Disease Test Volume Forecast France All Market Segments Infectious Disease Diagnostics Market Forecast France Hospital Laboratories Infectious Disease Diagnostics Market Forecast France Blood Banks Infectious Disease Diagnostics Market Forecast France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast France HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast Forecast by Market Segment France HIV Ag Test Volume and Diagnostics Sales Forecast By Market Segment France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment France Adenovirus Test Volume and Diagnostics Sales Forecast By Market Segment France Aeromonads Test Volume and Diagnostics Sales Forecast By Market Segment France BEA Test Volume and Diagnostics Sales Forecast by Market Segment France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment France Campylobacter Test Volume and Diagnostics Sales Forecast By Market Segment France Candida Test Volume and Diagnostics Sales Forecast By Market Segment France Chancroid Test Volume and Diagnostics Sales Forecast By Market Segment France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment France Coronavirus Test Volume and Diagnostics Sales Forecast By Market Segment France Coxsackievirus Test Volume and Diagnostics Sales Forecast By Market Segment France Cryptosporidium Test Volume and Diagnostics Sales Forecast By Market Segment France CMV Test Volume and Diagnostics Sales Forecast By Market Segment France Cyclospora Test Volume and Diagnostics Sales Forecast By Market Segment France E. Coli Test Volume and Diagnostics Sales Forecast By Market Segment France Echovirus Test Volume and Diagnostics Sales Forecast By Market Segment France Encephalitis Test Volume and Diagnostics Sales Forecast By Market Segment France Enterovirus Test Volume and Diagnostics Sales Forecast By Market Segment France EBV Test Volume and Diagnostics Sales Forecast By Market Segment France Giardia Test Volume and Diagnostics Sales Forecast By Market Segment France Gonorrhea Test Volume and Diagnostics Sales Forecast By Market Segment France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment France Hantavirus Test Volume and Diagnostics Sales Forecast By Market Segment France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment France HBsAg Test Volume and Diagnostics Sales Forecast By Market Segment France Hepatitis C Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HBc Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HBs Test Volume and Diagnostics Sales Forecast By Market Segment France Anti-HAV Test Volume and Diagnostics Sales Forecast By Market Segment France Hepatitis Delta Test Volume and Diagnostics Sales Forecast By Market Segment France HAV NAT Test Volume and Diagnostics Sales Forecast By Market Segment France HBV NAT Test Volume and Diagnostics Sales Forecast By Market Segment France HBcAg Test Volume and Diagnostics Sales Forecast By Market Segment France HBeAg Test Volume and Diagnostics Sales Forecast By Market Segment France ALT/SGPT Test Volume and Diagnostics Sales Forecast By Market Segment France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment France Herpes Type VI Test Volume and Diagnostics Sales Forecast By Market Segment

To order this report: In_Vitro_Diagnostic Industry: Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by Country : France, Germany, Italy, Japan, Spain, UK, US

________________________ Contact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001

Read the original:
Microbiology Testing: Granular Analysis of the Global Market : Supplier Shares and Forecasts for over 100 Diseases by ...

$3-Million Gift Will Advance Dairy Research, Innovation Capacity

Posted on by

July 08, 2013 - News Release

Keeping Ontario and Canada at the forefront of dairy production and health is the goal of a $3 million gift to the University of Guelph from the Dairy Farmers of Ontario (DFO).

It will support both a permanent faculty position in dairy microbiology at the Ontario Agricultural College (OAC) and a research chair in dairy cattle health at the Ontario Veterinary College (OVC). The gift was made through the BetterPlanet Project, the Universitys $200-million fundraising campaign for teaching and research in food, environment, health and communities.

This is a wonderful opportunity for the University and industry, said Rob Gordon, OAC dean. Across our University, there are dozens of professors, researchers and students engaged in dairy-related projects. This will allow us to further strengthen those efforts and support new innovations, as well as build new enthusiasm and excitement around our considerable dairy teaching, service and research.

Elizabeth Stone, OVC dean, said: Were grateful to DFO for its generous support. This gift will help us continue to make major improvements in dairy cattle health and food safety, and to train the scientists and veterinarians who protect the health of our dairy herds.

It will also enhance OVCs ability to recruit highly-qualified graduate students, find solutions to priority concerns confronting the industry, and strengthen collaborations between the University, government and industry, Stone said.

DFO will invest $200,000 a year in each position, with the OVC research chair being supported for five years and the OAC professorship for 10 years. The timing of the new positions coincides with the construction of a $25 million, state-of-the-art, dairy research facility at the U of G-run Elora Research Station; DFO is also committing up to $5 million on behalf of industry stakeholders.

DFO has enjoyed a longstanding relationship with the University of Guelph, and especially with OVC and OAC over the years, said Bill Emmott, chair of the DFO board of directors. We look forward to building on this excellent relationship for the benefit of the dairy producers and the industry we serve.

Peter Gould, DFO general manager and CEO, added that research is critical for the long-term viability of the industry. The areas of innovation, animal care, food safety, and productivity are key research priorities for DFO, he said.

OAC will be conducting a search through the Department of Food Science to fill the new dairy microbiology professorship, Gordon said. The focus will be on dairy microbiology; specifically probiotic and other beneficial microorganisms. This includes validating health benefits, proposing strategies to increase growth and survival of probiotics in dairy products and studying genetic modification to enhance health effects.

More here:
$3-Million Gift Will Advance Dairy Research, Innovation Capacity

Bharat Book Presents : Microbiology Testing Granular Analysis of the Global Market – Video

Posted on by


Bharat Book Presents : Microbiology Testing Granular Analysis of the Global Market
To know more : http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/microbiology-testing-granular-analysis-of-the-global-marke...

By: Deepa Kamath

Continued here:
Bharat Book Presents : Microbiology Testing Granular Analysis of the Global Market - Video

Fraser Health moves closer to merging microbiolgy labs

Posted on by

The executive director of pathology at the Provincial Health Services Authority swore two months ago that a portion of the microbiology lab at Burnaby Hospital would remain open.

But now, that tune appears to have changed.

Edward Ratnaraja says after discussion with clinicians and doctors, the decision was made to move all, not just part of the lab, to Royal Columbian Hospital.

And he says this is just the first phase of three to amalgamate all Fraser Health microbiology labs.

Phase two is moving the microbiology work again from Abbotsford Hospital to Surrey Memorial and the final phase sees all microbiology work being done in one hub hospital, which would be the Surrey Memorial tower.

Ratnaraja says they intend to have all the labs integrated within two years.

A spokesman with the Health Sciences Association, a union that represents lab technicians, says they understand the changes ahead but aren't thirlled with how they played out.

Reid Johnson says they were told the integration was going ahead only after it was already a done deal.

Our initial concern was the lack of notice and the failure to consult the people who actually do the specialized work to know what's best to do for the patient care.

Johnston says members understand efficiencies need to be made, and he is optimistic that moving forward, greater consultation will take place.

See the article here:
Fraser Health moves closer to merging microbiolgy labs

The CHU de Quebec and COPAN Achieve Landmark First Installation in North America of Next …

Posted on by

MURRIETA, Calif. The CHU de Quebec, one of the most important healthcare institutions in the province of Quebec and one of the biggest in Canada, and COPAN Diagnostics, Inc., announced today the full installation of WASPLab, the latest generation of full laboratory automation and digital microbiology system in Hopital de l'Enfant-Jesus, one of the five hospitals forming the CHU de Quebec. This hospital and COPAN group worked closely and collaboratively to deliver North America's fastest seamless solution for full laboratory automation. This is a historic first installation of a full laboratory automation and digital bacteriology system operational in North America. The installation of WASPLab's hardware took place in an unprecedented time of less than a week. The speed of installation means that disruption to the routine laboratory operations is minimal and Go-Live time after install is dramatically shortened.

"The Hopital de l'Enfant-Jesus is the first healthcare services provider to install and implement WASPLab in North America. This technology allows us to be more effective and efficient in our lab, which is very important from a budget point of view. It also allows us to face the shortage of qualified staff and appoint them to value-added tasks. Like most microbiology labs, we have a limited amount of space but with COPAN's WASPLab solution however, it allows us to bring in the latest technology for specimen processing, robotics, image analysis and digital reporting without having to tear down our lab," said Jean-Francois Gagnon, Microbiology Laboratory Manager at Hopital de l'Enfant-Jesus..

"COPAN values the close and collaborative relationships that enable us to innovate together by understanding our customers' needs and delivering solutions that achieve their highest goals for improving the ultimate quality of patient care," said Norman Sharples, CEO of COPAN Diagnostics, Inc. "WASPLab moves microbiology from what was essentially a batch process to an efficient and continuous automated flow from sample processing to incubation, reading, interpretation, work-up and reporting," added Sharples.

"WASPLab solution allows standardization of the planting and streaking and specimen processing, decreases risk of errors, and also lowers repetitive stress related to repeated movement for our staff" said Dr. Alain Paradis, Chief Microbiologist and Infectious Disease Specialist for Hopital de l'Enfant-Jesus, CHU de Quebec.

"We are excited to partner with the CHU de Quebec to help them achieve their goals. WASPLab's modular design and small footprint allowed us to customize it to Hopital de l'Enfant-Jesus needs in terms of technology and laboratory space constraints. WASPLab's small, high efficiency footprint eliminates unnecessary track that increases speed of positive culture plate availability, saves costs, reduces maintenance and avoids the artificial barriers extensive track creates within the lab," concluded Sharples.

COPAN will showcase WASPLab during AACC Clinical Lab Expo in Houston, Texas in July 2013.

About the CHU de Quebec Consist of the CHUL, L'Hotel-Dieu de Quebec and hospitals l'Enfant-Jesus, Saint-Francois d'Assise and du Saint-Sacrement, the CHU de Quebec is the most important health care institution in the province of Quebec and one of the biggest in Canada. The CHU de Quebec offers general and specialized care, but mostly ultra-specialized care throughout Eastern Quebec, which represents nearly two million persons. In partnership with Universite Laval and focused on the future, the CHU de Quebec also has core missions in teaching, in research in many fields of excellence, and in the evaluation of health technologies and professional practices.14,000 employees, 1,700 doctors, dentists and pharmacists, and also 500 researchers are needed to accomplish those missions.

About Copan Diagnostics, Inc. With a reputation for innovation, Copan is the leading manufacturer of collection and transport systems in the world. Copan's collaborative approach to preanalytics has resulted in Flocked Swabs, ESwab, Universal Transport Medium and modular laboratory automation, WASP and WASPLab. For more information about Copan Diagnostics, visit http://www.copanusa.com.

SOURCE Copan Diagnostics, Inc.

CONTACT: Gabriela Franco, Director of Marketing, (800) 216-4016, Gabriela.franco@copanusa.net

Read the rest here:
The CHU de Quebec and COPAN Achieve Landmark First Installation in North America of Next ...

Genomes of cholera bacteria from Haiti confirm epidemic originated from single source

Posted on by

Public release date: 2-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

The strain of cholera that has sickened thousands in Haiti came from a single source and was not repeatedly introduced to the island over the past three years as some have thought, according to a new study published in mBio, the online open-access journal of the American Society for Microbiology.

The results of this latest study are consistent with earlier findings that indicate Vibrio cholerae bacteria were introduced to Haiti by United nations soldiers between July and October 2010, when Nepalese soldiers arrived to assist recovery efforts after the January 2010 earthquake in that country. The genome sequences of V. cholerae strains from Haiti reveal they have not gained any new genetic material since their introduction and that they have a limited ability to acquire genes from other organisms through a process called transformation.

This new information may help public health authorities understand future cholera outbreaks in Haiti and elsewhere, according to the authors. "The use of high resolution sequence data that is amenable to evolutionary analysis will greatly enhance our ability to discern transmission pathways of virulent clones such as the one implicated in this epidemic," write the authors.

The earthquake in January 2010 killed tens of thousands of Haitians, and it was followed several months later by an outbreak of cholera, a disease that had never before been documented in Haiti. Studies of the outbreak indicate that poor sanitation at a United Nations camp resulted in sewage contamination of local water supplies, and phylogenetic analysis of the Haiti V. cholerae strains and strains from around the globe indicate the strain was most likely accidentally brought to the camp by U.N. troops from Nepal.

Earlier "fingerprinting" of Haiti's V. cholerae isolates using pulse-field gel electrophoresis (PFGE) has shown the bacterium has changed somewhat since the epidemic began in October 2010, but because of the nature of PFGE, the significance of those changes was not known. Were the changes meaningful? Were the bacteria gaining or losing genes that could impact the course of disease? Did they gain genes from other bacteria in the environment? Are their genomes rearranged? The answers could make a difference in the severity of future outbreaks.

The authors of the study in mBio set out to study in greater detail how V. cholerae may have evolved since its introduction to the island nation, and whether it has acquired genes that bestow new abilities. They sequenced the genomes of 23 different V. cholerae isolates from Haiti that represent multiple PFGE "fingerprint" patterns and were taken from a variety of locations and at various time points during the epidemic.

When compared with the genome sequences of V. cholerae strains from around the world, the Haiti isolates and three Nepal isolates are tightly related, forming a monophyletic group to which no other genome sequences belong.

This result indicates that "Nepalese isolates are the closest relatives to the Haiti strain identified to date, even when placed into a phylogeny with a larger collection of isolates representing recent cholera epidemics," write the authors. This means that the outbreak originated from a single introduction of bacteria, and PFGE variants arose from gradual evolution of the organisms, not from any secondary introduction.

See the rest here:
Genomes of cholera bacteria from Haiti confirm epidemic originated from single source

Prof. Hillary Lappin-Scott on Soapbox Science, public engagement, and microbiology – Video

Posted on by


Prof. Hillary Lappin-Scott on Soapbox Science, public engagement, and microbiology
Professor Hillary Lappin-Scott talks about her enthusiasm for taking part in Soapbox Science 2013 and the importance of both public engagement, and women in ...

By: Swansea Uni

Follow this link:
Prof. Hillary Lappin-Scott on Soapbox Science, public engagement, and microbiology - Video

Young students get real-life lessons in science

Posted on by

Published: Thursday, June 27, 2013 at 3:09 p.m. Last Modified: Thursday, June 27, 2013 at 3:09 p.m.

Nineteen students, ages 10 to 15, spent part of their summer vacation in a microbiology lab at the University of Florida, learning about tiny microbes that have a huge impact on humans.

Its something you cant see or hear, but microbes are everywhere, said Arjun Panicker, 13.

The first summer microbiology apprenticeship program at UF was launched by Monika Oli, a professor in the microbiology and cell science department and UFs current Teacher of the Year.

Oli, who has two children of her own, said there arent many opportunities for middle school-aged children to get laboratory experience, which might help draw them into science.

Its important to capture their attention now.

A lot of times, we lose students of that age group, especially girls, she said.

The apprenticeship program was designed to pique students interest in science, but also to show the intersections of science with art, culture and society.

To help make those connections, Oli invited guests to speak to the students, including other microbiology professors, artists and local author Shelley Fraser Mickle.

Above all, the program aimed to teach students real-life lessons about science.

Go here to see the original:
Young students get real-life lessons in science


  1. Microbiology